rediff.com
e.g. Tata motors, Reliance MF, 500570
Suven Pharmaceuticals Ltd - Receipt Of Observation Letter With 'No Adverse Observations' From BSE Limited And 'No Objection' From The National Stock Exchange Of India Limited For The Scheme Of Amalgamation
Download announcement < Back
23 Jul 2024
Receipt of Observation letter with &quot;no adverse observations&quot; from BSE and &quot;no objection&quot; from NSE for the scheme of amalgamation
View all announcements for Suven Pharmaceuticals Ltd Source: BSE India